The Department for Business, Enterprise and Regulatory Reform (BERR) was a UK government department responsible for business, enterprise, and regulatory affairs, and it was one of the predecessors of the Department for Business, Innovation and Skills (BIS).
A period during which a drug is protected from direct competition, granted by regulatory agencies to encourage the development of new treatments.
